Allergen Immunotherapy, Today and Tomorrow: Session I. Inhalant Allergens for Allergic Rhinitis and Asthma
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level One, Petree Hall C
2.50 CME/CE
Alkis Togias , MD FAAAAI

Learning Objectives:
  1. Discuss current and future approaches to allergen immunotherapy for asthma and allergic rhinitis
  2. Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
  3. Discuss the durability of immune unresponsiveness induced by allergen immunotherapy
7:00 AM
T Cell Epitope Changes During Allergen Immunotherapy and Allergen Exposure
Alessandro Sette, Dr. Biol. Sci.
7:25 AM
A Unique T Cell Subset (TH2A) in Allergen Immunotherapy
Erik R. Wambre, PhD MBE
7:50 AM
Peptide Immunotherapy in Allergic Rhinoconjunctivitis and Asthma
Mark Larché, PhD
  • LARCHE Handout AAAAI 2016.pdf (86.7 kB)
  • 8:15 AM
    Sublingual vs. Subcutaneous Immunotherapy: Which is More Potent?: The GRASS Trial
    Stephen R. Durham, MA MD FRCP
    8:55 AM
    How Can the Risk of Systemic Reactions to Subcutaneous Allergen Immunotherapy be Mitigated?
    Tolly Epstein, MD MS FAAAAI
  • 1001 course Epstein.pdf (559.2 kB)
  • 9:10 AM
    General Discussion
    See more of: Session